Concepedia
Statistics
Publications
16
Citations
858
H-Index
15
Active since
1992
Affiliations
Harvard University(Current)
Boston Children's Hospital
Whitehead Institute for Biomedical Research
Roswell Park Comprehensive Cancer Center
Massachusetts Institute of Technology
Thomas A. Natoli is an author at Harvard University specializing in life sciences, renal pathophysiology, and genetics.
Publications per year
1992–2020
Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models
Thomas A. Natoli, Laurie A. Smith, Kelly A. Rogers et al. · Nature Medicine · 2010 · 175 citations
Medicine, Nephrology, Pharmacology +8
Initial differentiation of the metanephric mesenchyme is independent of WT1 and the ureteric bud
Michael J. Donovan, Thomas A. Natoli, Kirsi Sainio et al. · Developmental Genetics · 1999 · 108 citations
Life Sciences, Developmental Biology, Genetics +17
A Mutant Form of the Wilms’ Tumor Suppressor Gene WT1 Observed in Denys-Drash Syndrome Interferes with Glomerular Capillary Development
Thomas A. Natoli, Jing Liu, Vera Eremina et al. · Journal of the American Society of Nephrology · 2002 · 71 citations
Medicine, Genetics, Molecular Genetics +17
CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD
Nikolay O. Bukanov, Sarah Moreno, Thomas A. Natoli et al. · Cell Cycle · 2012 · 66 citations · Full text
Medicine, Nephrology, Pharmacology +16
A Mammal-Specific Exon of <i>WT1</i> Is Not Required for Development or Fertility
Thomas A. Natoli, Alice McDonald, Julia A. Alberta et al. · Molecular and Cellular Biology · 2002 · 61 citations · Full text
Life Sciences, Genetics, Molecular Genetics +16
1–5 of 16